SS
OCUL icon

SBI Securities’s Ocular Therapeutix OCUL Stock Holding History

SBI Securities’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$334 Sell
34
-1
-3% -$9 ﹤0.01% 3169
2026
Q1 		$296 Buy
35
+4
+13% +$38 ﹤0.01% 3086
2025
Q4 		$376 Sell
31
-9
-23% -$109 ﹤0.01% 2978
2025
Q3 		$468 Sell
40
-16
-29% -$191 ﹤0.01% 2997
2025
Q2 		$520 Hold
56
– – ﹤0.01% 2947
2025
Q1 		$410 Buy
56
+20
+56% +$154 ﹤0.01% 2943
2024
Q4 		$307 Buy
+36
New +$351 ﹤0.01% 3076

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $161M AUM 27.24% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SBI Securities's OCUL Position: Q2 2026 in Review

SBI Securities reduced its Ocular Therapeutix (OCUL) stake by 2.9% in Q2 2026, selling an estimated $9 and leaving 34 shares worth $334. The position accounts for ﹤0.01% of the portfolio, ranked #3169.

SBI Securities first reported a position in OCUL in Q4 2024 and has held it in 7 quarters since. The position peaked at $520 in Q2 2025. 262 funds tracked by Wall St. Rank hold OCUL as of Q2 2026.

  • SBI Securities held 34 shares of Ocular Therapeutix worth $334 as of Q2 2026.
  • SBI Securities sold 1 Ocular Therapeutix share in Q2 2026, an estimated $9.
  • Ocular Therapeutix made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3169 holding.
  • SBI Securities first reported a position in Ocular Therapeutix in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Ocular Therapeutix position peaked at $520 in Q2 2025.
  • 262 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.